The syringes industry in the U.S. is experiencing growth because of the growing need for syringes that are safe, accurate, and efficient in the process of injections in hospitals, clinics, vaccination centers, pharmaceutical organizations, and at-home health care facilities. Syringes are used for delivering vaccines, biological medications, and treatment of diabetes and other conditions that require injection therapy, whereas safety syringes, auto-disable syringes, prefilled syringes, and specialty syringes are becoming popular to prevent cross contamination, needle sticks, and dosing errors.
According to SNS Insider, the U.S. Syringes Market was valued at USD 5.81 billion in 2025 and is expected to reach USD 13.26 billion by 2035, growing at a CAGR of 8.60% from 2026 to 2035. Globally, the market was valued at USD 17.00 billion in 2025 and is projected to reach USD 39.08 billion by 2035, registering a CAGR of 8.68%. The growth in the U.S. market is driven by the early adoption of safety-engineered syringes, the OSHA and FDA rules intended to decrease the risk of needle-stick injuries, as well as the wide availability of injectable products due to Medicare, Medicaid, and insurance companies. The growing number of biologicals, vaccines, insulin treatment, and specialized injectables is adding to syringes' demand.
Gain Actionable Intelligence on this Market – Request a Free Sample Report
Safety Regulations and Biologic Therapies Are Shaping U.S. Syringe Demand
The North America Syringes Market holds the largest revenue share of around 42.60% of the market in 2025 due to superior medical infrastructure, strong vaccination programs, and high prevalence of chronic diseases, such as diabetes and cancer, in the region's population. United States has become a significant contributor owing to the increased use of disposable, safety, and specialty syringes by healthcare institutions. CDC vaccination programs, safety regulation by OSHA and FDA, as well as the active contribution of pharmaceutical companies and health care providers, will further drive the market demand in coming years.
The vaccine and immunizations end user holds around 40.80% of the demand for applications of Syringes Market in 2025 owing to extensive vaccination campaigns and the extensive use of safety engineered, prefilled, and disposable syringes for safe injection purposes. Diabetic applications are seeing a faster demand growth owing to increasing prevalence of type I and type II diabetes among the aging as well as obese populations in addition to the growing dependence on insulin therapy. Biologics segment has contributed to increasing demand for prefilled and specialty syringes owing to cancer and autoimmune disease treatment requirements.
The disposable syringes comprised about 68.94% of the usage segment because of their low technology costs, one-time use nature, and high frequency of application in vaccinations, treatment, and diagnosis. The reusable syringes are projected to record fast growth due to their low cost, sustainability, and increasing application in veterinary and underdeveloped settings. The plastic syringes constituted about 60.14% of the material segment and are also projected to record fast growth due to their cost-effectiveness, lightweight nature, ease of manufacture, ability to incorporate safety features, and lower likelihood of breakage compared to glass.
Companies Supporting U.S. Syringe Innovation
Becton, Dickinson and Company
Becton, Dickinson and Company is a major international company in the field of healthcare technology, dealing specifically with medical devices, instruments, and reagents. This company concentrates on the areas of medication delivery, biosciences, and patient safety. Becton Dickinson offers its customers syringes, infusion systems, and diagnostics. Its activities include help to hospitals, vaccines, and biological products' administrations, and it is focused on precision, reliability, safety, and accessibility in healthcare. In March 2025, BD introduced advanced prefilled syringes with lower dead space.
B. Braun Melsungen AG
B. Braun is a multinational healthcare firm that manufactures medical devices, pharmaceutical products, and hospital services. The company concentrates on patient safety, sustainability, and innovation in the field of medication delivery, infusion therapy, and biologics administration. Syringe-based solutions from the company are used in hospitals, clinics, vaccination campaigns, and other healthcare applications. In January 2025, B. Braun launched eco-friendly and biodegradable syringes in Europe in order to reduce medical waste and ensure accurate dosing.
Terumo Corporation
Terumo Corporation is a global leader in medical devices manufacturing, specializing in vascular intervention, Cardiovascular Information System, and medical consumables. The company concentrates on syringes and injections technology, biologics delivery, and chronic disease management solutions. The key focus areas of the company are reliability, precision, scalability, and global quality and safety standards. In October 2024, Terumo extended its production facilities in India to increase supply of insulin and biologics syringes due to increased demand.
U.S. Syringes Market Outlook Through 2035
The market of U.S. Syringes will experience robust growth up until 2035 due to the increasing demand for injectable medicines, increasing prevalence of chronic illnesses, expanding vaccination program, and use of safety engineered syringes and auto-disable syringes. Moreover, the increasing application of biologics and biosimilars for the treatment of cancer, autoimmune disorders, and rare diseases will increase the demand for specialized and prefilled syringes which are used to administer viscous drugs accurately and efficiently.
While reaching USD 13.26 billion in 2035, demand will be driven by prefilled syringes, safety engineered syringes, biologic and insulin syringes, disposable syringes, and advanced injection technologies. Syringe manufacturers providing precise, safe, cost-effective, and patient-friendly solutions will continue playing an important role in the development of the U.S. market of injectable drug delivery and healthcare.
